Study of the Immune System during infection with Coronavirus in immunocompromised and cancer patients
Principal Investigators: Dr. Silvia Sánchez Ramón, from the Immunology Service, with the collaboration of Dr. Alberto Ocaña and Dr. Pedro Pérez Segura from the Medical Oncology Service and CRIS UNIT for New Experimental Therapies Centres: Hospital Clínico San Carlos. Current situation SARS-Cov-2, the coronavirus that has led to the COVID19 epidemic, has marked a turning
COVID19-H12O, sequencing the SARS-CoV-2 Coronavirus genome in infected blood cancer patients
Principal Investigators: Dr. Joaquín Martínez from the CRIS Unit for Haematological Tumours. Centre: Hospital 12 de Octubre, Madrid Current situation Since the year 2013, the CRIS Cancer Foundation has been supporting the CRIS Unit for Haematological Tumours (HUNET-CRIS) at the Hospital 12 de October. The Unit is currently carrying out 130 clinical trials and has so far
COVID19 project – HOSPITAL LA PAZ. Cell therapy with memory T cells in patients with severe COVID19
Principal Investigators: Dr. Antonio Pérez from the CRIS Unit for Advanced Therapies. Centres: Hospital de La Paz, Madrid. Current situation In 2018, the CRIS Cancer Foundation funded the construction of the CRIS Unit on the 8th floor of the Maternity Wing at the Hospital Universitario de la Paz. Coordinated by Antonio Pérez Martinez, this
Cancer Immunotherapy
Activating a person’s immune response against cancer is one of the most exciting advances in cancer therapy Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. Normally our immune system fails to recognise cancer cells, as they can look like normal cells in our body and are
Immuno-Oncology Unit at H12O
Lead Investigators: Dr. Luis Paz-Ares, Dr. Luis Álvarez-Vallina. Centre: 12th October University Hospital, Madrid, Spanish National Cancer Research Centre (CNIO). What is this project about? The concept of how cancer develops has changed radically over recent years. Tumours have ceased to be regarded as isolated bodies growing disconnected from their environment, and tumour cells
Multiple Myeloma Project (ICR)
Project: Resistance to treatments for Multiple Myeloma Institution: Institute of Cancer Research, London (UK) Researcher: Dr. Charlotte Pawlyn What is this project about? This research project aims to define a profile of multiple myeloma patients likely to develop resistance to myeloma treatments, study reasons why such resistance occurs and develop useful therapeutic strategies to overcome this. What is multiple myeloma? Multiple myeloma is a cancer that begins in
Breast Cancer Project
Principal Investigators: Dr Alberto Ocaña, Dr Atanasio Pandiella Centres: CHUA (University Hospital Complex of Albacete) – Albacete and CIC (Cancer Research Centre) – Salamanca Current situation Breast cancer is the most common type of cancer in women. It is estimated that one in ten women may suffer from it at some point in their lives. Although
Ovarian Cancer
El cáncer de ovario representa el sexto tumor más frecuente dentro de la población femenina en España. Tiene una mortalidad elevada, ya que no hay métodos de detección precoz y se suele diagnosticar cuando ya se encuentra diseminado.
Prostate Cancer Project
Principal Researcher: Dr David Olmos and Dr Elena Castro. Centres: Spanish National Cancer Research Centre (CNIO), IBIMA (Biomedical Research Institute of Malaga). Background: Prostate cancer is the most common cancer in men in the western world and its incidence increases year on year. It already ranks third as a cause of male cancer death, after
CRIS Unit for Translational Research and Clinical Trials in Haematology
Researcher leading the project: Dr. Joaquín Martínez Centres developing the research: 12 de Octubre University Hospital, Madrid, Spanish National Cancer Research Centre (CNIO). Context Haematological or blood cancer is a type of cancer that affects your blood cells. Over 40,000 people are diagnosed with a blood cancer each year in the UK, and over 250,000 people are currently